Therapeutic dilemmas in relapsing renal ANCA-associated vasculitis

Rheumatology (Oxford). 2021 Jun 17;60(Suppl 3):iii60-iii62. doi: 10.1093/rheumatology/keab178.

Authors

Ondrej Suchanek^{1

2}, David R W Jayne^{1

2}, Rachel B Jones^{1

2}

Affiliations

¹ Department of Medicine, University of Cambridge, Cambridge, UK.
² Vasculitis and Lupus Unit, Cambridge University Hospitals NHS Trust, Cambridge, UK.

PMID: 34137872
DOI: 10.1093/rheumatology/keab178

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Acute Kidney Injury / drug therapy*
Acute Kidney Injury / immunology
Aged
Anti-Inflammatory Agents / administration & dosage*
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / complications
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / drug therapy*
Humans
Immunologic Factors / administration & dosage*
Male
Prednisolone / administration & dosage*
Recurrence
Rituximab / administration & dosage*

Substances

Anti-Inflammatory Agents
Immunologic Factors
Rituximab
Prednisolone